FDA Approves Continuous Glucose Monitor for Children  The FDA has expanded the approval of the Dexcom G4 Platinum continuous glucose monitoring (CGM) system to include use for children aged 2 to 17 years of age despite reduced accuracy compared with adults. 

  Please share this resource with your patients….               By Osama Hamdy, MD, PhD, and Sheri R. Colberg, PhD  Who would ever have imagined that the often relentless progression of a chronic disease like type 2 diabetes can be stopped or reversed?

Patients who have had bariatric surgery may need to take dietary supplements and pay closer attention to their nutritional intake, a UT Southwestern Medical Center study suggests. The study tracked a group of gastric banding patients and found that despite nutritional counseling over a three-month period, most still did not …

When researchers at Emory’s Rollins School of Public Health followed 7,738 kids over the course of nine years they found that kindergarteners who were overweight had four times the risk of becoming obese by the age of 14 years as normal-weight kindergartners. More than 45% of the obesity cases that …

Diabetes patients who participated in a text message initiative attained significant reductions in A1c, greater satisfaction, and fewer visits to nondiabetes specialists at six months compared with a control group, a study indicated. Patients in the treatment arm also had lower medical expenses during the same period than the controls. …

A1c screening can reveal risk of type 2 before the disease begins to develop…. 

Potential of CKD misclassification due to increases in serum creatinine levels…. 

But SGLT-2 inhibitors still yield net reduction in plasma glucose, A1C, and weight…. A new class of drugs for type 2 diabetic patients known as sodium-glucose cotransporter 2 (SGLT-2) inhibitors are the latest thing used to reduce plasma glucose levels in the body. The SLGT-2 protein is responsible for about …

Elderly type 2 diabetic patients particularly vulnerable…. 

Hospital readmission rates in patients with poorly-controlled diabetes examined….